AU Stock MarketDetailed Quotes

IXC Invex Therapeutics Ltd

Watchlist
  • 0.072
  • 0.0000.00%
20min DelayNot Open Jul 23 11:45 AET
5.41MMarket Cap-699P/E (Static)

Invex Therapeutics Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Jun 30, 2023
(Q4)Jun 30, 2023
(FY)Jun 30, 2022
(Q4)Jun 30, 2022
(FY)Jun 30, 2021
(Q4)Jun 30, 2021
(FY)Jun 30, 2020
(Q4)Jun 30, 2020
Assets
Current assets
Cash, cash equivalents and short term investments
-23.41%22.47M
-23.41%22.47M
-10.32%29.34M
-10.32%29.34M
24.39%32.72M
24.39%32.72M
--26.3M
--26.3M
-Cash and cash equivalents
-23.41%22.47M
-23.41%22.47M
-10.32%29.34M
-10.32%29.34M
24.39%32.72M
24.39%32.72M
--26.3M
--26.3M
-Other receivables
-50.38%429.42K
-50.38%429.42K
33.70%865.44K
33.70%865.44K
-5.17%647.28K
-5.17%647.28K
--682.55K
--682.55K
Total current assets
-22.66%22.8M
-22.66%22.8M
-9.93%29.49M
-9.93%29.49M
23.92%32.74M
23.92%32.74M
--26.42M
--26.42M
Non current assets
Regulatory assets
128.92%333.57K
128.92%333.57K
587.37%145.72K
587.37%145.72K
-81.86%21.2K
-81.86%21.2K
--116.88K
--116.88K
Liabilities
Current liabilities
-accounts payable
723.58%1.14M
723.58%1.14M
1,124.55%138.78K
1,124.55%138.78K
-62.72%11.33K
-62.72%11.33K
--30.4K
--30.4K
-Total tax payable
--0
--0
--0
--0
--0
--0
--0
--0
Current liabilities
56.58%1.57M
56.58%1.57M
52.47%1M
52.47%1M
-67.32%658.61K
-67.32%658.61K
--2.02M
--2.02M
Non current liabilities
Total non current liabilities
56.58%1.57M
56.58%1.57M
52.47%1M
52.47%1M
-67.32%658.61K
-67.32%658.61K
--2.02M
--2.02M
Shareholders'equity
Share capital
0.00%36.41M
0.00%36.41M
0.00%36.41M
0.00%36.41M
34.78%36.41M
34.78%36.41M
--27.02M
--27.02M
-common stock
0.00%36.41M
0.00%36.41M
0.00%36.41M
0.00%36.41M
34.78%36.41M
34.78%36.41M
--27.02M
--27.02M
Gains losses not affecting retained earnings
26.38%2.4M
26.38%2.4M
23.05%1.9M
23.05%1.9M
57.75%1.54M
57.75%1.54M
--977.24K
--977.24K
Total equity
-22.66%22.8M
-22.66%22.8M
-9.93%29.49M
-9.93%29.49M
23.92%32.74M
23.92%32.74M
--26.42M
--26.42M
(FY)Jun 30, 2023(Q4)Jun 30, 2023(FY)Jun 30, 2022(Q4)Jun 30, 2022(FY)Jun 30, 2021(Q4)Jun 30, 2021(FY)Jun 30, 2020(Q4)Jun 30, 2020
Assets
Current assets
Cash, cash equivalents and short term investments -23.41%22.47M-23.41%22.47M-10.32%29.34M-10.32%29.34M24.39%32.72M24.39%32.72M--26.3M--26.3M
-Cash and cash equivalents -23.41%22.47M-23.41%22.47M-10.32%29.34M-10.32%29.34M24.39%32.72M24.39%32.72M--26.3M--26.3M
-Other receivables -50.38%429.42K-50.38%429.42K33.70%865.44K33.70%865.44K-5.17%647.28K-5.17%647.28K--682.55K--682.55K
Total current assets -22.66%22.8M-22.66%22.8M-9.93%29.49M-9.93%29.49M23.92%32.74M23.92%32.74M--26.42M--26.42M
Non current assets
Regulatory assets 128.92%333.57K128.92%333.57K587.37%145.72K587.37%145.72K-81.86%21.2K-81.86%21.2K--116.88K--116.88K
Liabilities
Current liabilities
-accounts payable 723.58%1.14M723.58%1.14M1,124.55%138.78K1,124.55%138.78K-62.72%11.33K-62.72%11.33K--30.4K--30.4K
-Total tax payable --0--0--0--0--0--0--0--0
Current liabilities 56.58%1.57M56.58%1.57M52.47%1M52.47%1M-67.32%658.61K-67.32%658.61K--2.02M--2.02M
Non current liabilities
Total non current liabilities 56.58%1.57M56.58%1.57M52.47%1M52.47%1M-67.32%658.61K-67.32%658.61K--2.02M--2.02M
Shareholders'equity
Share capital 0.00%36.41M0.00%36.41M0.00%36.41M0.00%36.41M34.78%36.41M34.78%36.41M--27.02M--27.02M
-common stock 0.00%36.41M0.00%36.41M0.00%36.41M0.00%36.41M34.78%36.41M34.78%36.41M--27.02M--27.02M
Gains losses not affecting retained earnings 26.38%2.4M26.38%2.4M23.05%1.9M23.05%1.9M57.75%1.54M57.75%1.54M--977.24K--977.24K
Total equity -22.66%22.8M-22.66%22.8M-9.93%29.49M-9.93%29.49M23.92%32.74M23.92%32.74M--26.42M--26.42M

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
AU
Overall
Symbol
Latest Price
% Chg